Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Fulphila
Fulphila Image

Fulphila

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Fulphila?

Fulphila is the brand name for a medication called pegfilgrastim-jmdb. It belongs to a class of drugs known as granulocyte colony-stimulating factors (G-CSFs). Fulphila is primarily used to help prevent a condition called neutropenia, which is a low white blood cell count, caused by receiving chemotherapy treatment. Neutropenia is a common side effect of chemotherapy, and it can increase the risk of developing infections. Fulphila works by stimulating the production of neutrophils, a type of white blood cell that plays a crucial role in the body's immune system defense against infections. By boosting the production of neutrophils, Fulphila helps to reduce the duration and severity of neutropenia, minimizing the risk of serious infections in individuals undergoing chemotherapy treatment. It is typically administered as an injection under the skin, either by a healthcare professional or self-administered by the patient after proper training. It's important to follow the prescribed dosage and administration instructions provided by the healthcare provider, as well as to monitor for any potential side effects or allergic reactions. These may include bone pain, muscle aches, injection site reactions, and allergic reactions such as rash or difficulty breathing. If you experience any concerning symptoms, it's essential to contact your healthcare provider for further guidance.

How to use Fulphila?

Fulphila, a brand-name prescription medication, is used to prevent neutropenia in individuals undergoing chemotherapy. Neutropenia is a condition characterized by a significant decrease in the number of neutrophils, a type of white blood cell, which increases the risk of infections. The specific dosing instructions for Fulphila may vary depending on the individual's condition, the type of chemotherapy being received, and other factors. It is essential to follow the instructions provided by your healthcare provider or the medication's labeling. Fulphila is typically administered as an injection under the skin (subcutaneously) or into a vein (intravenously). The injection should be given at the prescribed dose and frequency, as directed by your doctor. Always remember to carefully read the medication guide and consult your healthcare provider if you have any questions or concerns about using Fulphila. They will provide you with the necessary information and guidance for proper administration and usage of this medication.

Some of the warnings associated with the use of Fulphila (pegfilgrastim-jmbd) include: 1. Allergic Reactions: This medication can sometimes cause allergic reactions, which can be severe. Signs of an allergic reaction may include difficulty breathing, hives, swelling of the face or throat, and rash. If you experience any of these symptoms, seek immediate medical attention. 2. Spleen Rupture: There have been rare cases of spleen rupture reported with the use of pegfilgrastim products. If you experience sudden sharp or severe pain in the left upper abdomen or left shoulder, or if you feel lightheadedness or dizziness, it is important to contact your healthcare provider promptly. 3. Acute Respiratory Distress Syndrome (ARDS): ARDS, a potentially life-threatening lung condition, has been reported in patients receiving pegfilgrastim products. Symptoms to watch for include shortness of breath, difficulty breathing, and low oxygen levels. Seek medical attention if you experience any of these symptoms. 4. Increased Risk of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): There have been rare cases of MDS and AML reported in patients who have received pegfilgrastim products like Fulphila. Notify your healthcare provider if you experience symptoms such as unexplained fever, easy bruising or bleeding, frequent infections, or anemia. It is crucial to discuss these warnings with your healthcare provider and disclose any relevant medical history or current medications before starting Fulphila treatment. Your healthcare provider will carefully monitor you for any potential side effects or complications.

Before taking Fulphila, it is important to be aware of certain warnings and precautions. Fulphila is a medication used to prevent neutropenia, a condition characterized by an abnormally low white blood cell count, which can occur as a result of receiving chemotherapy. Here are some important points to consider: 1. Allergic Reactions: Prior to starting treatment with Fulphila, inform your healthcare provider if you have any known allergies, especially to filgrastim (the active ingredient in Fulphila) or other similar medications. Allergic reactions can be severe and require immediate medical attention. 2. Infection Risk: Fulphila works by stimulating the production of white blood cells, which are crucial for fighting off infections. However, it does not prevent all infections. It is important to be vigilant about practicing good hygiene and avoiding individuals with contagious illnesses. 3. Spleen Enlargement and Rupture: In rare cases, Fulphila can cause an enlargement of the spleen, which may lead to its rupture. If you experience severe pain or discomfort in the left upper abdomen, seek medical help immediately. 4. Lung Problems: Fulphila can cause a rare but serious lung problem called acute respiratory distress syndrome (ARDS). Symptoms of ARDS include difficulty breathing, rapid breathing, and low oxygen levels. Inform your healthcare provider if you experience any of these symptoms. 5. Allergic Cross-Reactivity: Use caution if you have a history of allergic reactions to latex products, as some formulations of filgrastim may contain latex. 6. Drug Interactions: Inform your healthcare provider about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Some medications may interact with Fulphila and affect its effectiveness or increase the risk of side effects. It is essential to discuss your medical history and any concerns you may have with your healthcare provider before starting Fulphila treatment. They can provide personalized advice and guidance based on your specific situation.

Fulphila is a brand-name medication that is used to prevent a condition called neutropenia, which is a low white blood cell count, that can occur as a side effect of chemotherapy treatment. It is classified as a biosimilar, which means it is highly similar to a previously approved biological product. Like any medication, Fulphila may cause certain side effects. The most common side effects reported with Fulphila include bone pain, muscle pain, pain in the extremities, pain in the joints, and general discomfort. Other potential side effects may include headache, fatigue, nausea, diarrhea, and fever. It's important to note that not everyone will experience these side effects, and some individuals may experience different or no side effects at all. If you are concerned about the side effects of Fulphila or if you experience any unusual or severe symptoms, it is important to contact your healthcare provider for further guidance. They will be able to provide specific information tailored to your individual situation.

The active ingredient in Fulphila is pegfilgrastim. It is a human granulocyte colony-stimulating factor (G-CSF) receptor agonist. In simpler terms, pegfilgrastim is a synthetic protein that mimics the natural G-CSF protein in the body, which helps in stimulating the production of white blood cells, specifically the neutrophils. Other than the active ingredient, Fulphila also contains other inactive ingredients that are necessary for its formulation. These ingredients can vary depending on the specific formulation or brand, but they generally include substances such as poloxamer 188, sodium acetate, glacial acetic acid, and sucrose. It is important to consult with a healthcare professional or check the medication label for the complete list of ingredients in Fulphila, as it may vary depending on the manufacturer and specific formulation.

Fulphila, also known as pegfilgrastim-jmdb, is a prescription medication used to prevent neutropenia, a condition characterized by a low level of neutrophils (a type of white blood cell), in individuals who are receiving chemotherapy. Proper storage is essential to maintain the effectiveness and safety of this medication. Fulphila should be stored in the refrigerator at a temperature between 36°F and 46°F (2°C to 8°C). It should be kept in its original packaging, protected from light, and away from moisture. Do not freeze the medication. If frozen, it should be discarded. It's important to note that once the medication is removed from the refrigerator and reaches room temperature, it should be used within 48 hours. If the product is not used within this time frame, it should be discarded as well. Always check the expiration date of the medication before using and never use expired products. If you have any concerns about the storage or usage of Fulphila, speak with your healthcare provider or pharmacist for further guidance.